Profile
| Metric | Value |
|---|---|
| Full Name | Quest Diagnostics Incorporated |
| Ticker | NYSE: DGX |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Country | United States |
| IPO | |
| Indexes | |
| Website | questdiagnostics.com |
| Employees | 55,000 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $174.44 | |
| Price, 1D Change | -1.86% | |
| Market Cap | $19B | |
| TTM Dividend Yield | 1.81% | |
| PE Ratio | 20.47 | |
| Beta | 0.25 | |
| Revenue | $10B | |
| Revenue, 1Y Change | +6.70% | |
| EPS | $7.66 | |
| EPS, 1Y Change | +1.88% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.80 | |
| Next Ex-Dividend | $0.80 | |
| Last Split | 2:1 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $7.66 | |
| EPS Estimate | $9.81 | |
| EPS Est. Change | +28.02% | |
| Revenue | $9.87B | |
| Revenue Estimate | $10.98B | |
| Revenue Est. Change | +11.26% | |
| Current Price | $174.44 | |
| Price Target | - | $200.00 |
| Price Tgt. Change | - | +14.65% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $8.71 | $7.52 | -13.64% | |
| $8.90 | $7.66 | -13.89% | |
| $9.81 | N/A | +28.02% | |
| $10.38 | N/A | +35.43% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $9.21B | $9.25B | +0.45% | |
| $9.83B | $9.87B | +0.41% | |
| $10.98B | N/A | +11.26% | |
| $11.38B | N/A | +15.30% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +13.25% | |
| Price, 3Y | +14.07% | |
| Market Cap, 1Y | +13.89% | |
| Market Cap, 3Y | +14.31% | |
| Revenue, 1Y | +6.70% | |
| Revenue, 3Y | -8.49% | |
| EPS, 1Y | +1.88% | |
| EPS, 3Y | -50.66% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $174.44 | |
| SMA 200 | $177.54 | |
| SMA 200 vs Price | +1.78% | |
| SMA 50 | $181.02 | |
| SMA 50 vs Price | +3.77% | |
| Beta | 0.25 | |
| ATR | $3.13 | |
| 14-Day RSI | 41.18 | |
| 10-Day Volatility | 25.18% | |
| 1-Year Volatility | 23.22% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $0.80 | |
| Upcoming | $0.80 | |
| Dividend Yield | 1.70% | |
| Total Dividend | $2.96 | |
| Dividends Paid | $331.00M | |
| Payout Ratio | 36.14% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $9.87B | |
| EPS | $7.66 | |
| Gross Profit | $3.24B | |
| Gross Margin | 32.86% | |
| Operating Profit | $1.35B | |
| Operating Margin | 13.63% | |
| Net Income | $916.00M | |
| Net Margin | 8.82% | |
| EBITDA | $1.87B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.92 | |
| Current Ratio | 1.10 | |
| Quick Ratio | 1.02 | |
| - | ||
| F-Score | 8 | |
| Altman Z-Score | 2.98 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 20.47 | |
| PS Ratio | 1.79 | |
| PB Ratio | 2.67 | |
| EV/EBITDA | 11.82 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $6.78B | |
| Cash & Equivalents | $549.00M | |
| Total Assets | $16.15B | |
| Current Assets | $2.39B | |
| Total Liabilities | $9.26B | |
| Current Liabilities | $2.17B | |
| Total Debt | $7.09B | |
| Short Term Debt | $775.00M | |
| Accounts Payable | $287.00M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $8.53B | |
| Operating Expenses | $1.90B | |
| Cost Of Goods Sold | $6.63B | |
| SG&A | $1.77B | |
| D&A | $493.00M | |
| Interest Expense | $0.00 | |
| Income Tax | $273.00M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $1.33B | |
| CFI | -$2.55B | |
| CFF | $1.08B | |
| Capex | $425.00M | |
| Free Cash Flow | $909.00M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Piper Sandler | → | |
| Truist Securities | → | |
| Barclays | → | |
| Leerink Partners | → | |
| Jefferies | → | |
| UBS | → | |
| Mizuho | → | |
| Evercore ISI Group | → | |
| Barclays | → | |
| Baird | → |
Analyst sentiment
Institutional ownership
Screeners with DGX
Data Sources & References
- DGX Official Website www.questdiagnostics.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1022079/000102207925000218/0001022079-25-000218-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1022079/000102207925000044/0001022079-25-000044-index.htm
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- DGX Profile on Yahoo Finance finance.yahoo.com/quote/DGX
- DGX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/dgx
FAQ
What is the ticker symbol for Quest Diagnostics Incorporated?
The ticker symbol for Quest Diagnostics Incorporated is NYSE:DGX
Does Quest Diagnostics Incorporated pay dividends?
Yes, Quest Diagnostics Incorporated pays dividends. The last payment was $0.80, with an ex-dividend date on October 3, 2025
What sector is Quest Diagnostics Incorporated in?
Quest Diagnostics Incorporated is in the Healthcare sector
What industry is Quest Diagnostics Incorporated in?
Quest Diagnostics Incorporated is in the Diagnostics & Research industry
What country is Quest Diagnostics Incorporated based in?
Quest Diagnostics Incorporated is headquartered in United States
When did Quest Diagnostics Incorporated go public?
Quest Diagnostics Incorporated initial public offering (IPO) was on December 17, 1996
Is Quest Diagnostics Incorporated in the S&P 500?
Yes, Quest Diagnostics Incorporated is included in the S&P 500 index
Is Quest Diagnostics Incorporated in the NASDAQ 100?
No, Quest Diagnostics Incorporated is not included in the NASDAQ 100 index
Is Quest Diagnostics Incorporated in the Dow Jones?
No, Quest Diagnostics Incorporated is not included in the Dow Jones index
When was Quest Diagnostics Incorporated last earnings report?
Quest Diagnostics Incorporated's most recent earnings report was on October 21, 2025
When does Quest Diagnostics Incorporated report earnings?
The next expected earnings date for Quest Diagnostics Incorporated is February 10, 2026
